Category: New York

Mediachain Secures $1,500,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ec749972-d7d3-4967-8885-29b6f6000197 Date 6/3/2016 Company Name Mediachain Mailing Address Undisclosed Brooklyn, NY 10011 USA Company Description Mediachain automatically connects media to its creator and information about it, and is a protocol for registering, identifying, and tracking creative works online. Website http://www.mediachain.io Transaction Type Venture Equity Transaction Amount $1,500,000 Transaction Round Seed Proceeds Purposes … Continue reading “Mediachain Secures $1,500,000 Seed Funding Round”

Mediamorph Obtains $11,122,664 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60c5a169-d553-48a1-ada4-6be646b0b59b Date 6/3/2016 Company Name Mediamorph Mailing Address 205 Lexington Avenue 7th Floor New York, NY 10016 USA Company Description Mediamorph is a leader in the cloud computing software sector, providing business support to the media industry. Our goal is to help you better understand your business and the digital environment within … Continue reading “Mediamorph Obtains $11,122,664 New Financing Round”

SeedInvest Receives $5,125,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e111bbd-e6ba-4c90-855d-b1050230b642 Date 6/3/2016 Company Name SeedInvest Mailing Address 447 W Broadway New York, NY 10013 USA Company Description SeedInvest is an equity-based, crowdfunding platform that connects accredited investors to high-quality start-ups and small businesses seeking funding. Website http://www.seedinvest.com Transaction Type Venture Equity Transaction Amount $5,125,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “SeedInvest Receives $5,125,000 New Financing”

Ethoplex Eyes Residential Customers for Fast Internet Service

Last month, federal antitrust regulators officially cleared the $65 billion merger between Charter Communications (NASDAQ: [[ticker:CHTR]]) and Time Warner Cable, two of the country’s leading cable and Internet service providers (ISPs). The deal will bring some minor changes for residential Internet users in the Milwaukee area, where Time Warner had amassed significant market share. For … Continue reading “Ethoplex Eyes Residential Customers for Fast Internet Service”

A Startup CEO Visits Cuba in Transition

I just returned from several days visiting Cuba with several of my BFFs. No amount of pre-reading prepared me for the wonderful experience. Americans cannot go as “tourists,” but must go on an approved people-to-people exchange. As such, we visited schools, farms, a university, children’s programs, museums, churches, a factory and the like. I’m sharing … Continue reading “A Startup CEO Visits Cuba in Transition”

Silicon Valley Vets Aim to Shake Up Preclinical Testing With Vium

Cancer drugs have cured countless mice, only to fall short in people. It’s a well-known problem with drug development: Preclinical tests done on animals can be inaccurate, and that drives up the cost and time it takes to make a successful therapeutic. Several startups are developing technologies to improve preclinical testing—microchips that act like human … Continue reading “Silicon Valley Vets Aim to Shake Up Preclinical Testing With Vium”

RubiconMD Secures $4,000,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=403ed086-b2fb-4c80-8b38-139d7bce05f9 Date 6/2/2016 Company Name RubiconMD Mailing Address 483 Broadway 2nd Floor New York, NY 10013 USA Company Description RubiconMD connects local clinics to top specialists, enabling quick remote consults that eliminate unnecessary referrals and reduce patient wait time and travel burden. The platform redesigns primary health care, by bringing appropriate clinical … Continue reading “RubiconMD Secures $4,000,000 Series A Financing”

theSkimm Secures $8,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0e43a24a-9fe9-4c01-b7b7-547decd2ef76 Date 6/2/2016 Company Name theSkimm Mailing Address 30 East 20th Street New York, NY 10003 USA Company Description theSkimm is the daily newsletter that simplifies the headlines for the educated professional who knows enough to know she needs more. We do the reading for you and explain it with fresh editorial … Continue reading “theSkimm Secures $8,000,000 Series B Funding”

Armarium Lands $1,250,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=75748bde-c670-4028-8354-e552e5d3eaca Date 6/2/2016 Company Name Armarium Mailing Address 1 East 52nd St. New York, NY 10022 USA Company Description Armarium is the premiere destination for on-demand luxury. Members are provided with access to the runway’s most coveted pieces– all of which can be borrowed whenever needed. Website http://www.armarium.com Transaction Type Venture Equity … Continue reading “Armarium Lands $1,250,000 Seed Funding Round”

SevenFifty Obtains $8,500,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=95b12740-f15d-4e11-94b8-e56b689ce6f9 Date 6/2/2016 Company Name SevenFifty Mailing Address 337 E 8th St. New York, NY 10009 USA Company Description SevenFifty has made my life infinitely more efficient and it has made purchasing wine for the restaurants infinitely more agreeable. Thank you, SevenFifty, for freeing up hours of my life so that I … Continue reading “SevenFifty Obtains $8,500,000 Series A Financing”

Flatiron School Helps Refugees; Cornell Tech Hires Ex-Yahoo Scientist

The technology education scene in the city has seen interesting moves of late—particularly at the Flatiron School and Cornell Tech. Today, New York-based Flatiron School announced it is working with Re:Coded, a humanitarian nonprofit, to provide a curriculum to Syrian refugees in Iraq to help them find work as software developers. And last week, Cornell … Continue reading “Flatiron School Helps Refugees; Cornell Tech Hires Ex-Yahoo Scientist”

Zibby Lands $12,500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0cd950d1-21fb-4945-8cf1-55561b79351f Date 6/1/2016 Company Name Zibby Mailing Address 31 West 26th Street New York, NY 10010 USA Company Description Zibby’s lease-to-own option lets you pay monthly for the items you want today. Website http://www.zibby.com Transaction Type Venture Equity Transaction Amount $12,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed by … Continue reading “Zibby Lands $12,500,000 New Round”

Verto Analytics Secures $16,100,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2164272d-ec47-4a33-8646-8b4ee8b9c452 Date 6/1/2016 Company Name Verto Analytics Mailing Address 79 Madison Ave 2nd Floor New York, NY 10016 USA Company Description Verto Analytics is a pioneer in digital media measurements with a focus on syndicated research and analytics. The company provides a complete portfolio of measurement services covering the digital and hardware … Continue reading “Verto Analytics Secures $16,100,000 Series B Financing”

HOOCH Obtains $950,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ece2cee2-6ad8-4695-9914-eabf82976f1d Date 6/1/2016 Company Name HOOCH Mailing Address Undisclosed New York, NY 10022 USA Company Description HOOCH launched exclusively in New York in November 2015 on both iOS and Android. The HOOCH app is available for free download in the Apple App Store and on Google Play. Website http://www.hooch.co Transaction Type Venture … Continue reading “HOOCH Obtains $950,000 Series A Funding”

Two Years After Paying $680M, BioMarin Shelves Duchenne Drug

BioMarin Pharmaceutical took a $680 million gamble when it bought Prosensa in 2014 for its experimental Duchenne muscular dystrophy treatment. Drisapersen (Kydrisa) had already failed a Phase 3 trial, but BioMarin bet it could dig through the data and win FDA approval. It lost that bet, and now BioMarin (NASDAQ: [[ticker:BMRN]]) is pulling the plug … Continue reading “Two Years After Paying $680M, BioMarin Shelves Duchenne Drug”

Microsoft Venture Fund Aims to Harness Early Stage Innovation

Microsoft plans to invest more in early stage startup companies through a new corporate venture fund, headed by former Qualcomm executives. The name of the fund—which will back startups focused on cloud computing, machine learning, and security, with an emphasis on technology that complements Microsoft’s own products and services—is Microsoft Ventures. If that sounds familiar, … Continue reading “Microsoft Venture Fund Aims to Harness Early Stage Innovation”

Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug

Amicus Therapeutics is as familiar with the ups and downs of the drugmaking business as anyone. It has dealt with clinical failures, regulatory setbacks, restructurings, and more over a roughly 15-year history. But now the Cranbury, NJ-based company’s big day has finally arrived: Regulators in Europe have approved migalastat (Galafold), the first Amicus drug to … Continue reading “Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug”

Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma

All it takes to become an acquisition target in biotech is some promising data. Take Ewing, NJ, and Vancouver-based Celator Pharmaceuticals, which Jazz Pharmaceuticals just agreed to buy this morning for $1.5 billion. Celator (NASDAQ: [[ticker:CPXX]]) was formed in 1999 by a team led by Lawrence Mayer and Marcel Bally, both veterans of the British … Continue reading “Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma”

Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease

[Updated, 5/31/16, see below] The FDA ended a busy week by giving a thumbs-up late Friday to obeticholic acid as a treatment for primary biliary cirrhosis, a rare disease in which a patient’s own immune system attacks the liver. Obeticholic acid, to be marketed under the brand Ocaliva, is being developed by Intercept Pharmaceuticals (NASDAQ: … Continue reading “Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease”

Busy FDA Week Ends With Two Drug Approvals: Another Might Be on Way

The new FDA commissioner Robert Califf told a conference audience this week that he expected “a flood” of new treatments in the near future. Perhaps he meant the following few days. His agency approved two drugs to close out the week, and another decision is due by Sunday. The FDA announced late Friday afternoon that … Continue reading “Busy FDA Week Ends With Two Drug Approvals: Another Might Be on Way”

With Recruits Coming, Precision Med Effort Pledges $142M For Biobank

The Obama administration’s ambitious long-term health study, dubbed the Precision Medicine Initiative, has tapped the Mayo Clinic to build a repository for biological samples collected from the study’s participants. Through the National Institutes of Health, the administration has awarded $142 million over five years to the Rochester, MN-based Mayo Clinic for the so-called “biobank,” which … Continue reading “With Recruits Coming, Precision Med Effort Pledges $142M For Biobank”

117M LinkedIn Passwords for Sale: What You Should Do Now

Last week, a hack many of us had forgotten about shot right back into the headlines. First, the background: in 2012, LinkedIn acknowledged it had suffered a data breach that exposed the passwords of 6.5 million of its customers. What we discovered last week, however, was that the breach was actually much bigger than anyone … Continue reading “117M LinkedIn Passwords for Sale: What You Should Do Now”

Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More

Memorial Day weekend may be fast approaching, but don’t fire up those grills yet: there’s plenty of headlines to dig into first in our biotech trip around the Xconomy network. In New York, the nation’s most prestigious science competition changed sponsors for just the second time in its 74-year history. In Boston, one company’s controversial … Continue reading “Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More”

Skillshare Lands $12,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5d49953f-354d-4ff8-a6fe-489d1d7c9cd1 Date 5/27/2016 Company Name Skillshare Mailing Address 284 Mott St. New York, NY 10012 USA Company Description Skillshare is a community marketplace to learn anything from anyone. We believe that everyone has valuable skills and knowledge to teach and the curiosity to keep learning new things. This means our neighborhoods, communities … Continue reading “Skillshare Lands $12,000,000 Series B Round”

FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming

New FDA commissioner Robert Califf said Wednesday that the recent spike in drug approvals is no temporary phenomenon, thanks to a better understanding of biology and continued adoption of sophisticated technology throughout healthcare. “I predict we’ll see of a flood of effective treatments”—not just drugs but combinations of drugs and data-enabled devices—“and we’ll have to … Continue reading “FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming”

Minerva’s Shares Soar on Early Data for Schizophrenia Drug

Schizophrenia affects millions of people around the world, which is why any prospective treatment that advances garners close attention. Minerva Neurosciences jumped into the spotlight this morning when an experimental schizophrenia drug it’s developing showed some promise in a mid-stage trial, sending the company’s shares soaring. Now the Waltham, MA-based biotech has to prove that … Continue reading “Minerva’s Shares Soar on Early Data for Schizophrenia Drug”

Arrivo BioVentures Lands $49M to Fuel Hunt for New Drugs

Usually when a biotech company makes a large fundraising announcement, the cash is committed to taking a specific drug through clinical trials. Arrivo BioVentures has secured $49 million in capital to first find the drugs to develop. The approach is similar to what the Morrisville, NC-based company’s management team did with three previous biotech firms, … Continue reading “Arrivo BioVentures Lands $49M to Fuel Hunt for New Drugs”

Untapt Garners $458,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7ab9350e-cff4-4dc5-a1a2-00759f5842e6 Date 5/26/2016 Company Name Untapt Mailing Address 225 West 35th Street New York, NY 10018 USA Company Description untapt is the next generation digital hiring platform for technologists and employers. It uses machine intelligence to match candidates with open jobs in tech. Our powerful data-driven platform uses complete candidate and hiring-side … Continue reading “Untapt Garners $458,000 New Funding”

Dashlane Lands $22,500,000 Series C Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0cc93f0d-f15c-4f95-bfb3-6e8b040081a8 Date 5/26/2016 Company Name Dashlane Mailing Address 73 Spring Street New York, NY 10012 USA Company Description Dashlane is rated the best password manager. Autofill with our free form filler. Save receipts, payment types, passwords & personalize your digital wallet. Website http://www.dashlane.com Transaction Type Venture Equity Transaction Amount $22,500,000 Transaction Round … Continue reading “Dashlane Lands $22,500,000 Series C Round”

GetTaxi Obtains $300,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb1156b0-b652-4ffa-8642-7902dcf7c0bf Date 5/26/2016 Company Name GetTaxi Mailing Address 237 West 35th St. New York, NY 10001 USA Company Description GetTaxi (operating under “GetTaxi” brand in Europe and “Gett” in USA) is Europe’s largest on-demand car service company by revenues and is the leading player in the B2B space globally. Website http://www.gettaxi.com Transaction … Continue reading “GetTaxi Obtains $300,000,000 New Funding”

BigID Secures $2,100,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=178dfe14-890b-4152-9da1-e2d0c8bc3409 Date 5/26/2016 Company Name BigID Mailing Address Undisclosed New York, NY 10022 USA Company Description BigID is an early stage security company focused on helping organizations protect the privacy of their customer data through a first of its kind enterprise privacy management platform. Website http://www.bigid.com Transaction Type Venture Equity Transaction Amount … Continue reading “BigID Secures $2,100,000 Seed Round”

Seismic Raises $40M to Expand Web-based Software for Big Customers

Seismic is making some waves today. The suburban San Diego software company, which specializes in “sales enablement” and content management software for big companies and organizations, says it has raised $40 million in a Series C funding round led by General Atlantic. JMI Equity, an existing investor, also participated in the round. Gary Reiner, a … Continue reading “Seismic Raises $40M to Expand Web-based Software for Big Customers”

Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug

The multi-year saga of eteplirsen, a Duchenne muscular dystrophy drug from Cambridge, MA-based Sarepta Therapeutics, will continue to drag on. Sarepta (NASDAQ: [[ticker:SRPT]]) said today that the FDA won’t complete its review of its drug, eteplirsen, by the established May 26 deadline. As a result, rather than approve or reject eteplirsen—which has the chance to … Continue reading “Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug”

A Front Row 5,000 Rows Deep in AltspaceVR’s Virtual Theater

Can a concert in a virtual auditorium sell out? To get the best seat, does your avatar have to camp out overnight at the virtual ticket booth? The questions that come up as virtual reality works its way into the real consumer world are often as mind-bending as Zen koans. But entrepreneurs have already cooked … Continue reading “A Front Row 5,000 Rows Deep in AltspaceVR’s Virtual Theater”

Wellth Garners Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7bba8a7c-764a-4747-bc53-b5bfa48af9ff Date 5/25/2016 Company Name Wellth Mailing Address Undisclosed New York, NY 10022 USA Company Description Wellth works together with healthcare payors to produce cost-saving behavior changes in their members through science-based incentive plans. Website http://www.wellthapp.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Series A Proceeds Purposes This investment will … Continue reading “Wellth Garners Series A Financing Round”

Retooled Selecta Bio Takes Crossover Cash to IPO Queue

Selecta Biosciences became a candidate to go public when a group of crossover investors—institutions that back both public and private companies—piled $38 million into the company in September. Nine months later, the Watertown, MA-based company is ready to take the leap. Selecta filed papers with the Securities and Exchange Commission late Tuesday outlining plans for … Continue reading “Retooled Selecta Bio Takes Crossover Cash to IPO Queue”

Steve Blank Hails NYU Engineering Grads, Talks Building Businesses

Make the most of the days to come while ignoring a few rules along the way was some of the advice Steve Blank shared Monday in a commencement speech for this year’s graduates at NYU Tandon School of Engineering. Known for his methodologies that helped drive the lean startup movement, Blank is a former serial entrepreneur who … Continue reading “Steve Blank Hails NYU Engineering Grads, Talks Building Businesses”

Software Robots Are Transforming Old Guard Industries

Everyone’s talking about robots and automation. Do you imagine having a “Rosie” cleaning your home, or the next industrial revolution of automation putting millions out of work? Neither is quite reality, but there is a highly valuable virtual workforce of “software robots” working in today’s offices. They aren’t rolling around like BB-8 delivering the mail, … Continue reading “Software Robots Are Transforming Old Guard Industries”

SeamlessDocs Lands $7,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f088f74f-de5e-40b3-aba2-41f291bd7b21 Date 5/23/2016 Company Name SeamlessDocs Mailing Address 30 Vandam Street New York, NY 10013 USA Company Description SeamlessDocs is a modern replacement to the PDF. The current PDF is a dumb document that needs to be downloaded, is not mobile friendly and has no validation or workflow built in. Website http://www.seamlessdocs.com … Continue reading “SeamlessDocs Lands $7,000,000 Series B Financing”

Take The Interview Obtains $5,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83ba2e5c-880c-451a-9db5-9a7b0f40c041 Date 5/23/2016 Company Name Take The Interview Mailing Address 307 West 38th Street 13th Floor New York, NY 10018 USA Company Description Take the Interview improves organizational efficiency, reduces time-to-hire and improves the quality of hire, making recruiters and hiring managers happier with their recruiting process. Website http://www.taketheinterview.com Transaction Type Venture … Continue reading “Take The Interview Obtains $5,000,000 Series B Financing Round”

Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug

Back in 2012, Acorda Therapeutics bought a Morrisville, NC, company called Neuronex as part of a plan to branch out beyond its flagship multiple sclerosis drug dalfampridine (Ampyra). Unfortunately, the drug, a nasal spray form of the old seizure control drug diazepam, never lived up to expectations, leading Acorda today to shelve it altogether. Ardsley, … Continue reading “Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug”

The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More

A quick housekeeping note: Starting this week, we are combining our East Coast and West Coast biotech roundups into a single weekly post that will also include highlights from our other cities and regions, including Texas, Michigan, Wisconsin, and Xconomy’s latest bureau, Indiana. As with our bygone coastal roundups, this new national roundup is not … Continue reading “The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More”

Empire Genomics Lands $1,750,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83e803be-0723-4a88-bd0e-679d97b893eb Date 5/20/2016 Company Name Empire Genomics Mailing Address 700 Michigan Ave. Buffalo, NY 14203 USA Company Description Our mission is to improve individual patient care through the integration of innovative molecular diagnostic technology. Website http://www.empiregenomics.com Transaction Type Venture Equity Transaction Amount $1,750,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Empire Genomics Lands $1,750,000 New Funding Round”

Krossover Obtains $20,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fed78e36-bd8b-46fb-ba1d-d1d6b05e88f7 Date 5/20/2016 Company Name Krossover Mailing Address 148 W 24th Street 8th Floor New York, NY 10011 USA Company Description At Krossover, our passion is designing and building tools that help coaches and athletes win. We are rapidly growing our team with the best and the brightest talent who share our … Continue reading “Krossover Obtains $20,000,000 Series B Financing”

Spark Adds To Early But Promising Data For Hemophilia Gene Therapy

The race to develop a gene therapy for hemophilia just moved another few feet forward. Spark Therapeutics, which is one of several companies developing a treatment, is the latest to provide its first glimpse of clinical data in human patients. As with other snippets from rivals like UniQure, of Amsterdam, and BioMarin Pharmaceutical, of San … Continue reading “Spark Adds To Early But Promising Data For Hemophilia Gene Therapy”

General Assembly Brings Tech Training Event to San Antonio Saturday

San Antonio—General Assembly and San Antonio co-working space Geekdom are hosting a day of free tech workshops and training in San Antonio this weekend. The event is being held Saturday at the Geekdom Event Centre starting at 2 p.m. and is open to the public, though the hosts are asking for online RSVPs here. The … Continue reading “General Assembly Brings Tech Training Event to San Antonio Saturday”

Smartling Acquires VerbalizeIt for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b772e95b-4da7-4562-9652-5692218d0008 Date 5/19/2016 Company Name VerbalizeIt Mailing Address 141 West 28th 7th Floor New York, NY 10001 USA Company Description VerbalizeIt delivers real-time access to human translators to make sure that nothing is ever lost in translation. We empower businesses and travelers with the ability to instantly connect with a live translator … Continue reading “Smartling Acquires VerbalizeIt for Undisclosed Sum”

Avanan Secures $14,900,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ead6be66-f6a9-4831-a6ab-268f160acade Date 5/18/2016 Company Name Avanan Mailing Address 137 Varick St. 2nd Floor New York, NY 10013 USA Company Description AVANAN protects your data in the cloud with the same industry-leading security you trust in your datacenter. The cloud-based platform is completely out-of-band, requires no proxy, and can be deployed in just … Continue reading “Avanan Secures $14,900,000 Series A Financing Round”